Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kissei Pharmaceutical Co., Ltd. KSPHF

Full chart Compare
Set alert

Price alert · KSPHF

All alert types
24.50 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

30.28 Day range 30.28
24.50 52-week range 31.90
YTD
-9.16%
1 year
-2.39%

Financial health

Altman Z-Score

4.05 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 3
  • P/B 5

Valuation

P/E 12.2×
FY 2017: 2151×FY 2018: 1609×FY 2019: 2836×FY 2020: 4050×FY 2021: 21.7×FY 2022: 9.2×FY 2023: 10.9×FY 2024: 14.1×FY 2025: 13.0×FY 2026: 12.2×
FY 2017 5y median 12.2× FY 2026
P/S 1.7×
FY 2017: 231×FY 2018: 197×FY 2019: 215×FY 2020: 181×FY 2021: 1.7×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 2.1×FY 2025: 1.8×FY 2026: 1.7×
FY 2017 5y median 1.8× FY 2026
P/B 0.7×
FY 2017: 105×FY 2018: 82.8×FY 2019: 85.3×FY 2020: 59.4×FY 2021: 0.5×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.7×FY 2026: 0.7×
FY 2017 5y median 0.7× FY 2026
P/FCF -26.5×
FY 2017: 4244×FY 2018: 2302×FY 2019: 3589×FY 2020: 943×FY 2021: -986×FY 2022: -3441×FY 2023: -1099×FY 2024: -44.7×FY 2025: 105×FY 2026: -26.5×
FY 2017 5y median -44.7× FY 2026
EV/EBITDA 83.6×
FY 2017: 11.9×FY 2018: 9.6×FY 2019: 14.4×FY 2020: 14.9×FY 2021: 24.9×FY 2022: 51.4×FY 2023: 39.2×FY 2024: 7.2×FY 2025: 6.5×FY 2026: 83.6×
FY 2017 5y median 39.2× FY 2026
EV/Sales 1.4×
FY 2017: 230×FY 2018: 196×FY 2019: 214×FY 2020: 183×FY 2021: 1.7×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 1.5×FY 2026: 1.4×
FY 2017 5y median 1.7× FY 2026
FCF Yield -3.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.1%FY 2021: -0.1%FY 2022: -0.0%FY 2023: -0.1%FY 2024: -2.2%FY 2025: 1.0%FY 2026: -3.8%
FY 2017 5y median -0.1% FY 2026

Profitability

Gross Margin 47.0%
FY 2017: 64.1%FY 2018: 64.0%FY 2019: 61.8%FY 2020: 53.6%FY 2021: 0.4%FY 2022: 0.4%FY 2023: 0.3%FY 2024: 49.4%FY 2025: 49.9%FY 2026: 47.0%
FY 2017 5y median 47.0% FY 2026
Operating Margin -3.0%
FY 2017: 11.8%FY 2018: 13.4%FY 2019: 8.6%FY 2020: 2.9%FY 2021: 2.2%FY 2022: -2.1%FY 2023: -1.7%FY 2024: 5.3%FY 2025: 6.5%FY 2026: -3.0%
FY 2017 5y median -1.7% FY 2026
Net Margin 14.1%
FY 2017: 10.8%FY 2018: 12.2%FY 2019: 7.6%FY 2020: 4.5%FY 2021: 7.7%FY 2022: 19.8%FY 2023: 15.6%FY 2024: 14.8%FY 2025: 13.5%FY 2026: 14.1%
FY 2017 5y median 14.8% FY 2026
ROE 6.0%
FY 2017: 4.9%FY 2018: 5.1%FY 2019: 3.0%FY 2020: 1.5%FY 2021: 2.4%FY 2022: 6.4%FY 2023: 5.4%FY 2024: 5.1%FY 2025: 5.7%FY 2026: 6.0%
FY 2017 5y median 5.7% FY 2026
ROIC -0.9%
FY 2017: 1.8%FY 2018: 2.0%FY 2019: 1.2%FY 2020: 0.3%FY 2021: 1.4%FY 2022: -1.3%FY 2023: -1.0%FY 2024: 1.3%FY 2025: 1.9%FY 2026: -0.9%
FY 2017 5y median -0.9% FY 2026
ROA 5.0%
FY 2017: 4.1%FY 2018: 4.3%FY 2019: 2.6%FY 2020: 1.2%FY 2021: 217.2%FY 2022: 660.6%FY 2023: 632.3%FY 2024: 4.3%FY 2025: 4.9%FY 2026: 5.0%
FY 2017 5y median 5.0% FY 2026

Growth (YoY)

Revenue 11.0%
FY 2017: 1.5%FY 2018: 8.1%FY 2019: -6.1%FY 2020: -10.3%FY 2021: 11685.4%FY 2022: -5.3%FY 2023: 3.2%FY 2024: 12.0%FY 2025: 16.9%FY 2026: 11.0%
FY 2017 FY 2026
Operating Income -151.0%
FY 2017: -16.6%FY 2018: 22.0%FY 2019: -39.7%FY 2020: -69.3%FY 2021: 8649.2%FY 2022: -193.2%FY 2023: 19.5%FY 2024: 455.8%FY 2025: 43.7%FY 2026: -151.0%
FY 2017 FY 2026
EPS (diluted) 21.8%
FY 2017: -4.1%FY 2018: 24.6%FY 2019: -40.1%FY 2020: -47.2%FY 2021: 20123.2%FY 2022: 147.4%FY 2023: -18.5%FY 2024: 8.0%FY 2025: 11.2%FY 2026: 21.8%
FY 2017 FY 2026
Free Cash Flow -529.8%
FY 2017: 13.1%FY 2018: 69.7%FY 2019: -34.2%FY 2020: 187.1%FY 2021: -203.5%FY 2022: 70.4%FY 2023: -204.4%FY 2024: -3251.5%FY 2025: 142.5%FY 2026: -529.8%
FY 2017 FY 2026

Financial Health

Current Ratio 5.3×
FY 2017: 6.2×FY 2018: 5.6×FY 2019: 6.9×FY 2020: 5.7×FY 2021: 5.1×FY 2022: 5.3×FY 2023: 6.7×FY 2024: 5.9×FY 2025: 6.5×FY 2026: 5.3×
FY 2017 5y median 5.9× FY 2026
Quick Ratio 4.1×
FY 2017: 5.1×FY 2018: 4.7×FY 2019: 5.9×FY 2020: 4.9×FY 2021: 5.1×FY 2022: 4.3×FY 2023: 5.2×FY 2024: 4.4×FY 2025: 4.9×FY 2026: 4.1×
FY 2017 5y median 4.4× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -16.5×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: 0.2×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.4×FY 2024: -1.2×FY 2025: -1.2×FY 2026: -16.5×
FY 2017 5y median -1.2× FY 2026
Interest Coverage -105×
FY 2017: 354×FY 2018: 430×FY 2019: 270×FY 2020: 80.7×FY 2021: 65.4×FY 2022: -61.0×FY 2023: -56.5×FY 2024: 223×FY 2025: 275×FY 2026: -105×
FY 2017 5y median -56.5× FY 2026

Dividends

Dividend Yield 2.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 1.6%FY 2020: 2.2%FY 2021: 2.2%FY 2022: 2.1%FY 2023: 2.7%FY 2024: 2.4%FY 2025: 2.4%FY 2026: 2.9%
FY 2017 5y median 2.4% FY 2026
Payout Ratio 35.1%
FY 2017: 28.5%FY 2018: 25.1%FY 2019: 4622.5%FY 2020: 9128.5%FY 2021: 46.8%FY 2022: 19.6%FY 2023: 29.8%FY 2024: 33.4%FY 2025: 31.8%FY 2026: 35.1%
FY 2017 5y median 31.8% FY 2026

Annual · latest fiscal year ends 2026-03-31